Marta Villalba Montaner Institucions de les que formen part Investigador predoctoral Vall Hebron Institut de Recerca
Projectes CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY RELATED MALIGNANCIES IP: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY Col·laboradors: Marta Villalba Montaner, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Bárbara Tazón Vega, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Silvia Saumell Tutusaus, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY Entitat finançadora: Instituto de Salud Carlos III Finançament: 215380 Referència: PI20/00881 Durada: 01/01/2021 - 31/12/2023
